Search - tctmd.com

Displaying 1 - 20 of 22

Sort: Relevancy | Date

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

L.A. McKeown

March 12, 2025

News Conference News CRT 2025

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

L.A. McKeown

March 10, 2025

News Conference News CRT 2024

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

L.A. McKeown

March 12, 2024

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

News Conference News

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

Todd Neale

March 01, 2022

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Todd Neale

March 08, 2021

News Conference News CRT 2020

Long-term Survival Data Promising for Carillon Repair Device in Functional MR

L.A. McKeown

March 03, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

News Conference News CRT 2020

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

L.A. McKeown

February 27, 2020

News Conference News CRT 2020

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

Michael O'Riordan

February 26, 2020

News Conference News CRT 2020

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

L.A. McKeown

February 25, 2020

News Conference News CRT 2020

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

L.A. McKeown

February 24, 2020

News Conference News CRT 2019

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

Yael L. Maxwell

March 04, 2019

News Conference News CRT 2019

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Yael L. Maxwell

March 04, 2019

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

News Conference News CRT 2018

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Michael O'Riordan

March 05, 2018

Presentation CRT 2018

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

Presenter: Ron Waksman

March 04, 2018

News Conference News CRT 2017

Amid Sluggish Trial Enrollment, Transcatheter Mitral Valve Field Asks: Just How Big Is the Unmet Need?

Michael O'Riordan

February 27, 2017

Advertisement

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

SMART: Small Aortic Annuli Still Fare Best With Self-Expandable Valves at 2 Years

Open SESAME? Transcatheter Myotomy Shows Promise for LVOT Obstruction

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Longer-Term LRT Results ‘Encouraging’ for TAVI in Low-risk Patients

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Long-term Survival Data Promising for Carillon Repair Device in Functional MR

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

AKI After TAVR Is Decreasing, but More Efforts Needed to Prevent Stage 3

Less Leaflet Thrombosis in Low-Risk TAVR Patients Treated With Oral Anticoagulation

BIOFLOW V: Orsiro Bests Xience at 3 Years for TLF, Late Stent Thrombosis

Small Study Hints Rivaroxaban Helps Cut Stroke in A-fib Patients Post-TAVR

BASILICA Leaflet Laceration Before TAVR Helps Prevent Coronary Obstruction

One-Year Data on Low-Risk TAVR Continue to Show Good Safety: LRT

Ticagrelor: Better Platelet Blockade Post-TAVR?

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Is COAPT Designed to Fail? Experts Debate Treatment Timing in Severe Functional MR

Transcatheter Aortic Valve Replacement for Patients with Severe Aortic Stenosis who are at Low Risk For Mortality: Interim results from the Prospective Multicenter LRT Clinical Trial

Amid Sluggish Trial Enrollment, Transcatheter Mitral Valve Field Asks: Just How Big Is the Unmet Need?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content